Programs SCARDA

List of our Programs

Programs	Overview
Program on R&D of new generation vaccine including new modality application	With regard to the prioritized infectious diseases stipulated by the government, AMED aims to provide in Japan and overseas safe and efficient vaccines that can make an international contribution in the event of an infectious disease emergency at the earliest possible juncture. Accordingly, in anticipation of an infectious disease emergency, support is provided for (i) infectious disease vaccine development and (ii) research and development into new modalities contributing to vaccine development through integrated and flexible allocation of budgets. (Vaccine Strategy 2.2)
Japan Initiative for World-leading Vaccine Research and Development Centers	Aiming for the achievement of Japanese-made vaccines, world-leading research and development centers (a flagships center, centers promising synergetic effects) and institutions to support research and development are set up. At these research centers, we strengthen and promote vaccine-related research aiming to achieve practical results during normal times. (Vaccine Strategy 2.1)

Programs

Overview

Program on R&D of new generation vaccine including new modality application

With regard to the prioritized infectious diseases stipulated by the government, AMED aims to provide in Japan and overseas safe and efficient vaccines that can make an international contribution in the event of an infectious disease emergency at the earliest possible juncture. Accordingly, in anticipation of an infectious disease emergency, support is provided for (i) infectious disease vaccine development and (ii) research and development into new modalities contributing to vaccine development through integrated and flexible allocation of budgets. (Vaccine Strategy 2.2)

Japan Initiative for World-leading Vaccine Research and Development Centers

Aiming for the achievement of Japanese-made vaccines, world-leading research and development centers (a flagships center, centers promising synergetic effects) and institutions to support research and development are set up. At these research centers, we strengthen and promote vaccine-related research aiming to achieve practical results during normal times. (Vaccine Strategy 2.1)

Last updated 09/24/25